FOI release

Post-Brexit MHRA gene therapy products: submission and authorization date(s)

Some or all of the information requested was not provided because we determined that the cost to do so would exceed the appropriate limit.

Case reference FOI2026/00090

Received 28 January 2026

Published 9 March 2026

Request

Please provide the submission date(s) and UK marketing authorisation (approval) date for all MHRA-authorised gene therapy products approved after Brexit, and please provide the results as an Excel file (or, if not possible, as a CSV table) listing product name, submission date(s), and approval date.

Response

See attached

Documents

• FOI2026_00090 (redacted).pdf (556.6 KB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.